Once-daily ceftriaxone therapy for serious bacterial infections in children

B. L. Congeni, T. Chonmaitree, T. A. Rakusan, Q. T. Box

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Ceftriaxone administered as a single daily dose of 50 mg/kg was evaluated in the treatment of 35 children with a variety of nonmeningitic bacterial infections. In two of the patients, the drug discontinued before the response to the drug could be evaluated. All of the remaining patients had a satisfactory response. In 22 of the patients, plasma was available for the determination of ceftriaxone levels 1 h after a dose and immediately before the next dose. All but one of these patients had trough ceftriaxone levels which exceeded the MIC of the infecting organism, although marginally so for Staphylococcus aureus. Ceftriaxone appears to be safe and effective in the treatment of a variety of bacterial pathogens in children when administered at a single daily dose of 50 mg/kg. This drug may be especially useful in those patients in whom outpatient antibiotic therapy is contemplated or in whom maintenance of intravenous access is difficult.

Original languageEnglish (US)
Pages (from-to)181-183
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume27
Issue number2
StatePublished - 1985
Externally publishedYes

Fingerprint

Ceftriaxone
Bacterial Infections
Pharmaceutical Preparations
Therapeutics
Staphylococcus aureus
Outpatients
Maintenance
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Congeni, B. L., Chonmaitree, T., Rakusan, T. A., & Box, Q. T. (1985). Once-daily ceftriaxone therapy for serious bacterial infections in children. Antimicrobial Agents and Chemotherapy, 27(2), 181-183.

Once-daily ceftriaxone therapy for serious bacterial infections in children. / Congeni, B. L.; Chonmaitree, T.; Rakusan, T. A.; Box, Q. T.

In: Antimicrobial Agents and Chemotherapy, Vol. 27, No. 2, 1985, p. 181-183.

Research output: Contribution to journalArticle

Congeni, BL, Chonmaitree, T, Rakusan, TA & Box, QT 1985, 'Once-daily ceftriaxone therapy for serious bacterial infections in children', Antimicrobial Agents and Chemotherapy, vol. 27, no. 2, pp. 181-183.
Congeni, B. L. ; Chonmaitree, T. ; Rakusan, T. A. ; Box, Q. T. / Once-daily ceftriaxone therapy for serious bacterial infections in children. In: Antimicrobial Agents and Chemotherapy. 1985 ; Vol. 27, No. 2. pp. 181-183.
@article{e32c30aae599435a97d649348e7018db,
title = "Once-daily ceftriaxone therapy for serious bacterial infections in children",
abstract = "Ceftriaxone administered as a single daily dose of 50 mg/kg was evaluated in the treatment of 35 children with a variety of nonmeningitic bacterial infections. In two of the patients, the drug discontinued before the response to the drug could be evaluated. All of the remaining patients had a satisfactory response. In 22 of the patients, plasma was available for the determination of ceftriaxone levels 1 h after a dose and immediately before the next dose. All but one of these patients had trough ceftriaxone levels which exceeded the MIC of the infecting organism, although marginally so for Staphylococcus aureus. Ceftriaxone appears to be safe and effective in the treatment of a variety of bacterial pathogens in children when administered at a single daily dose of 50 mg/kg. This drug may be especially useful in those patients in whom outpatient antibiotic therapy is contemplated or in whom maintenance of intravenous access is difficult.",
author = "Congeni, {B. L.} and T. Chonmaitree and Rakusan, {T. A.} and Box, {Q. T.}",
year = "1985",
language = "English (US)",
volume = "27",
pages = "181--183",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Once-daily ceftriaxone therapy for serious bacterial infections in children

AU - Congeni, B. L.

AU - Chonmaitree, T.

AU - Rakusan, T. A.

AU - Box, Q. T.

PY - 1985

Y1 - 1985

N2 - Ceftriaxone administered as a single daily dose of 50 mg/kg was evaluated in the treatment of 35 children with a variety of nonmeningitic bacterial infections. In two of the patients, the drug discontinued before the response to the drug could be evaluated. All of the remaining patients had a satisfactory response. In 22 of the patients, plasma was available for the determination of ceftriaxone levels 1 h after a dose and immediately before the next dose. All but one of these patients had trough ceftriaxone levels which exceeded the MIC of the infecting organism, although marginally so for Staphylococcus aureus. Ceftriaxone appears to be safe and effective in the treatment of a variety of bacterial pathogens in children when administered at a single daily dose of 50 mg/kg. This drug may be especially useful in those patients in whom outpatient antibiotic therapy is contemplated or in whom maintenance of intravenous access is difficult.

AB - Ceftriaxone administered as a single daily dose of 50 mg/kg was evaluated in the treatment of 35 children with a variety of nonmeningitic bacterial infections. In two of the patients, the drug discontinued before the response to the drug could be evaluated. All of the remaining patients had a satisfactory response. In 22 of the patients, plasma was available for the determination of ceftriaxone levels 1 h after a dose and immediately before the next dose. All but one of these patients had trough ceftriaxone levels which exceeded the MIC of the infecting organism, although marginally so for Staphylococcus aureus. Ceftriaxone appears to be safe and effective in the treatment of a variety of bacterial pathogens in children when administered at a single daily dose of 50 mg/kg. This drug may be especially useful in those patients in whom outpatient antibiotic therapy is contemplated or in whom maintenance of intravenous access is difficult.

UR - http://www.scopus.com/inward/record.url?scp=0021823312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021823312&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 181

EP - 183

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -